Mechanism of Action of Borate-Based Bioactive Glass Fiber Matrix in Stimulating Cell Proliferation, Gene Expression, and Angiogenesis
Year: 2026
Type: article
Abstract: Background: The objective of this study was to examine the mechanism of action (MOA) of a borate-based bioactive glass fiber matrix (BBGFM) technology, Mirragen® Advanced Wound Matrix (Engineered Tissue Solutions, US), supported by multimodal and multispecies observations. Methods: This study used cell proliferation assays with primary adult human dermal microvascular endothelial cells (HMVEC-dAd). A diabetic mouse delayed-wound-healing model was used to compare gene expression on Day 14 between BBGFM-treated and untreated control wounds. A porcine model was also used to study vessel density and the number of new vessel objects in a porcine pocket-incision model treated with BBGFM at 0%, 25%, 50%, or 100% of the full material thickness. Results: Cell proliferation assays indicated that BBGFM at 5 mg/mL significantly increased the cell-proliferation signal after 24 hours but not at lower or higher concentrations (1 and 20 mg/mL). The 5 mg/mL concentration also significantly increased cell proliferation after 48 hours, although the difference was not statistically significant. NanoString gene expression studies in a diabetic Db/Db mouse delayed wound-healing model, indicate that BBGFM significantly downregulates the following genes (adjusted p-value <0.05): Tnfsf13, Faah, Itgax, Gnas, and Dnmt3a; it was also found to significantly upregulate 19 genes: Ctgf, Vegfa, Jun, Itgav, Gzmb, Rln1, Il1rn, Shh, Gata4, Il17a, Il10, Cxcl1, S100a8, Csf2, Ptgs2, Csf3, Cxcl2, S100a9, and Il1a. In a porcine defect (5 × 5 cm) and incision model, BBGFM was found to stimulate angiogenesis based on blood vessel density analysis of CD31 (PECAM-1) antibody staining. The negative control had limited CD31 vasculature after 3 and 6 weeks. Increasing BBGFM thickness was associated with progressively higher vessel-object density with statistical significance for 100% thickness. Conclusions: Our cross-species studies suggest that BBGFM may promote endothelial-cell activation through direct and indirect mechanisms, potentially through macrophage-mediated signaling that promotes angiogenesis. We hypothesize that higher BBGFM concentrations are required in vivo to be effective and that BBGFM acts on multiple cell types to cause direct and indirect activation of endothelial cells, which may support angiogenesis and wound repair.
DOI: 10.67702/ipfg8316
Language: English
Topic: Wound Healing and Treatments
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,806
OpenAlex ID: W7233746627
